NephroGenex, Inc (NRX) Reports Q2 Loss of $0.61/Share
Tweet
Share
E-mailGet Alerts NRX Hot Sheet
Join SI Premium – FREE
NephroGenex, Inc (NASDAQ: NRX) reported Q2 EPS of ($0.61), versus ($2.51) reported last year.
For earnings history and earnings-related data on NephroGenex, Inc (NRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
